In January 2024, Qinhuangdao Taizhi Medical Technology Co., Ltd. was officially selected as a preferred member unit in the medical protective equipment industry under the Brand Power Nation Selection Project, and was awarded the honorary titles of "Preferred Member Unit of the Brand Power Nation Independent Brand Selection Project - Medical Mask Industry" and "First Place Among the Top Ten Medical Mask Brands." Over the past years, this medical device company, originating from Qinhuangdao, has been writing a new chapter from "product export" to "brand export" with its solid qualification system and continuously expanding international market share.

The Brand Powerhouse Preferred Project is a national demonstration platform for independent brands, organized by the “Discovery Brands” TV programme and co-organized by the China International Brand Strategy Research Centre at the University of International Business and Economics (UIBE). Being selected signifies that a company meets stringent standards in product quality, technological innovation and operational management. For Taizhi Medical, this recognition is not only a powerful endorsement of its brand value, but also a pivotal milestone in its strategic shift from “riding on others’ coattails” to “sailing its own course” in the global marketplace.

The confidence behind Taizhi Medical’s brand-building efforts rests first on solid manufacturing capabilities and a robust compliance framework. The company has a registered capital of CNY 110 million, operates over 2,000 square metres of Class 100,000 clean workshops, and runs a total of 36 production lines, including 15 fully automated intelligent lines, with a daily output exceeding 2 million units. It is listed as a key epidemic-prevention material producer in Hebei Province, and appears on both the National Medical Products Administration (NMPA) whitelist and the China Chamber of Commerce for Import & Export of Medicines & Health Products (CCCMHPIE) whitelist. Its products hold EU CE, US FDA, UK UKCA and Australian TGA certifications, and the company is ISO 13485 certified for medical device quality management. This comprehensive certification portfolio, covering all major Western markets, forms Taizhi Medical’s “passport” to global competition.

Driven by its brand strength, Taizhi Medical has continued to expand its overseas footprint. Today, with its headquarters in Qinhuangdao, the company maintains strong business relationships with medical device distributors, serving thousands of customers worldwide. Its product range includes medical protective ear-loop masks, medical protective respirators, disposable surgical masks, KN95 flat-fold protective masks, children’s protective masks, and more—allowing the company to meet the varied regulatory and consumer preferences of different international markets. Meanwhile, the company’s Taizhi Medical Science & Technology Innovation Centre project is progressing rapidly, scheduled for completion and commissioning in 2026, which will provide a new strategic pillar for further R&D and capacity expansion.

From its rapid production ramp-up during the pandemic to today’s global brand strategy, Taizhi Medical’s trajectory reflects a profound shift in China’s medical protection industry. As the sector transitions from a volume-driven race to one defined by quality and brand equity, Taizhi Medical empowered by its Brand Power recognition, is accelerating its evolution from a pure product supplier into an integrated exporter of technology, standards and brand value. Looking ahead, the company will continue to deepen its expertise in medical protection, leveraging its solid technical foundations and rising brand reputation to present a positive image of Chinese medical device enterprises on the world stage.